Silicon Laboratories Inc. (NASDAQ:SLAB) Shares Sold by Algert Global LLC

Algert Global LLC decreased its position in Silicon Laboratories Inc. (NASDAQ:SLAB) by 5.8% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 9,513 shares of the semiconductor company’s stock after selling 582 shares during the period. Algert Global LLC’s holdings in Silicon Laboratories were worth $1,182,000 as of its most recent SEC filing.

Other large investors also recently made changes to their positions in the company. Jones Financial Companies Lllp grew its position in Silicon Laboratories by 44.5% in the 4th quarter. Jones Financial Companies Lllp now owns 224 shares of the semiconductor company’s stock valued at $28,000 after buying an additional 69 shares in the last quarter. Headlands Technologies LLC bought a new position in shares of Silicon Laboratories in the fourth quarter valued at approximately $70,000. Venturi Wealth Management LLC raised its holdings in Silicon Laboratories by 207.0% during the fourth quarter. Venturi Wealth Management LLC now owns 786 shares of the semiconductor company’s stock worth $98,000 after purchasing an additional 530 shares in the last quarter. Asset Management One Co. Ltd. acquired a new stake in Silicon Laboratories in the fourth quarter worth approximately $117,000. Finally, KBC Group NV boosted its stake in Silicon Laboratories by 42.1% during the 4th quarter. KBC Group NV now owns 1,279 shares of the semiconductor company’s stock valued at $159,000 after purchasing an additional 379 shares in the last quarter.

Analysts Set New Price Targets

SLAB has been the topic of a number of research reports. Stifel Nicolaus cut their price objective on Silicon Laboratories from $145.00 to $120.00 and set a “buy” rating for the company in a report on Thursday, April 17th. KeyCorp upped their price target on shares of Silicon Laboratories from $115.00 to $160.00 and gave the company an “overweight” rating in a report on Wednesday, January 22nd. Needham & Company LLC reiterated a “buy” rating and issued a $150.00 target price on shares of Silicon Laboratories in a report on Wednesday, March 12th. Benchmark restated a “buy” rating and set a $160.00 target price on shares of Silicon Laboratories in a report on Wednesday, March 12th. Finally, StockNews.com cut Silicon Laboratories from a “hold” rating to a “sell” rating in a report on Thursday, March 27th. One research analyst has rated the stock with a sell rating, three have issued a hold rating and five have issued a buy rating to the stock. According to MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $129.00.

Silicon Laboratories Stock Up 5.4 %

Shares of NASDAQ:SLAB opened at $117.04 on Friday. The company has a market cap of $3.80 billion, a P/E ratio of -19.70 and a beta of 1.36. The company’s fifty day moving average is $108.95 and its two-hundred day moving average is $120.50. Silicon Laboratories Inc. has a 12-month low of $82.82 and a 12-month high of $160.00.

Silicon Laboratories (NASDAQ:SLAB) last announced its quarterly earnings data on Tuesday, February 4th. The semiconductor company reported ($0.11) EPS for the quarter, hitting analysts’ consensus estimates of ($0.11). The firm had revenue of $166.25 million during the quarter, compared to analyst estimates of $166.09 million. Silicon Laboratories had a negative return on equity of 10.46% and a negative net margin of 32.69%. The business’s quarterly revenue was up 91.4% compared to the same quarter last year. During the same period last year, the company posted ($1.19) EPS. Equities research analysts anticipate that Silicon Laboratories Inc. will post -0.97 earnings per share for the current year.

Insider Transactions at Silicon Laboratories

In related news, Director Christy Wyatt sold 546 shares of the stock in a transaction on Tuesday, May 6th. The stock was sold at an average price of $104.45, for a total transaction of $57,029.70. Following the completion of the sale, the director now directly owns 8,492 shares in the company, valued at approximately $886,989.40. This trade represents a 6.04 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director William G. Bock sold 1,000 shares of the business’s stock in a transaction dated Tuesday, February 18th. The shares were sold at an average price of $149.43, for a total value of $149,430.00. Following the completion of the transaction, the director now owns 31,115 shares in the company, valued at $4,649,514.45. This trade represents a 3.11 % decrease in their position. The disclosure for this sale can be found here. 1.60% of the stock is owned by insiders.

About Silicon Laboratories

Silicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.